Outcomes of a Medicare Part D telephone medication therapy management program

Journal of the American Pharmacists Association

Volumn 52, Issue 6, 2012, Pages

  Moczygemba, Leticia R ^a   Barner, Jamie C ^b   Gabrillo, Evelyn R ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Medicare Part D; Medication therapy management; Medication related problems; Pharmacists; Telephone

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; NON PRESCRIPTION DRUG; THYROTROPIN;

AGE; AGED; ARTICLE; CHRONIC DISEASE; COLONOSCOPY; CONTROLLED STUDY; COST CONTROL; DEPRESSION; DIABETES MELLITUS; DIABETIC FOOT; DRUG COST; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; EYE EXAMINATION; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; INFLUENZA VACCINATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MEDICARE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; PHARMACIST; QUASI EXPERIMENTAL STUDY; RACE; SIGMOIDOSCOPY; TELECONSULTATION; TETANUS PROPHYLAXIS;

EID: 84886723584     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.11258     Document Type: Article

References (42)

1. Centers for Medicare & Medicaid Services. Medicare prescription drug benefit final rule. Accessed at www.cms.hhs.gov/providerupdate/regs/CMS4068F. pdf, February 21, 2005.
2. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
3. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46:133-47.
4. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23-31.
5. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project IMPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
6. Goode JK, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project IMPACT: Osteoporosis. J Am Pharm Assoc. 2004;44:152-60.
7. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23:113-32.
8. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-71.
9. McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. J Am Pharm Assoc. 2003;43:511-18.
10. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-37.
11. Smith SR, Catellier DJ, Conlisk EA, Upchurch GA. Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes. Am J Health Syst Pharm. 2006;63:372-9.
12. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218-26.
13. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104-11.
14. Stebbins MR, Kaufman DJ, Lipton HL. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services. J Manag Care Pharm. 2005;11:333-41.
15. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203-11.
16. Lewis NJ, Bugdalski-Stutrud C, Abate MA, et al. The medication assessment program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48:171-80.
17. Christensen DB, Roth M, Trygstad T, Byrd J. Evaluation of a pilot medication therapy management project within the North Carolina state health plan. J Am Pharm Assoc. 2007;47:471-83.
18. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566-72.
19. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J Am Pharm Assoc. 2005;45:573-9.
20. United States Centers for Medicare & Medicaid Services. 2011 Medicare Part D medication therapy management program fact sheet. Accessed at www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/ downloads//MTMFactSheet2011063011Final.pdf, May 1, 2012.
21. Moczygemba LR, Goode JV, Gatewood SB, et al. Integration of collaborative medication therapy management in a safety net patient-centered medical home. J Am Pharm Assoc. 2011;51:167-72.
22. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16:185-95.
23. Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving medication management in primary care. Health Affairs (Millwood). 2011;4:646-54.
24. Patient-Centered Primary Care Collaborative. The patient-centered medical home: integrating comprehensive medication management to optimize patient outcomes. Accessed at www.pcpcc.net/files/medmanagepub.pdf, August 4, 2011.
25. Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice: a report to the U.S. Surgeon General, Office of the Chief Pharmacist. Washington, DC: U.S. Public Health Service; 2011.
26. Pindolia VK, Stebelsky L, Romain TM, et al. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother. 2009;43:611-20.
27. Winston S, Lin Y. Impact on drug cost and use of Medicare Part D of medication therapy management services in 2007. J Am Pharm Assoc. 2009;49:813-20.
28. Fox D, Ried LD, Klein GE, et al. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc. 2009;49:192-9.
29. Moczygemba LR, Barner JC, Gabrillo ER, Godley PJ. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries. Am J Health Syst Pharm. 2008;65:1655-60.
30. Moczygemba LR, Barner JC, Lawson KA, et al. The impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow-up. Am J Geriatr Pharmacother. 2011;9:328-38.
31. Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749-54.
32. Vik SA, Maxwell CJ, Hogan DB, et al. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol. 2005;12;e152-64.
33. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:231-55.
34. George J, Phun YT, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369-76.
35. Dolder NM, Dolder CR. Comparison of a pharmacist-managed lipid clinic: in-person versus telephone. J Am Pharm Assoc. 2010;50:375-8.
36. Oderda L, Holman C, Nichols B, et al. Pharmacist-managed telephone clinic review of antidementia medication effectiveness. Consult Pharm. 2011;26:264-73.
37. Moczygemba LR, Barner JC, Brown CM, et al. Patient satisfaction with a pharmacist-provided telephone medication therapy management service. Res Social Adm Pharm. 2010;6:143-54.
38. Academy of Managed Care Pharmacy. Sound medication therapy management programs: version 2.0 with validation study. J Manag Care Pharm. 2008;14(1 suppl B):s2-44.
39. Perera PN, Guy MC, Sweaney AM, et al. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). J Manag Care Pharm. 2011;17:345-54.
40. Alston G, Hanrahan C. Can a pharmacist reduce annual costs for Medicare Part D enrollees? Consult Pharm. 2011;26:182-9.
41. Hansen RA, Kim MM, Song L, et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413-22.
42. Karve S, Cleves MA, Helm M, et al. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25:2303-10.